Costs of Care and Adherence to Treatment for Cystic Fibrosis

Costs of Care and Adherence to Treatment for Cystic Fibrosis.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02832479

Acronym

COMURA MUCOBS

Enrollment

500

Registered

2016-07-14

Start date

2014-10-31

Completion date

2016-02-29

Last updated

2016-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Brief summary

Evolution of medical care for patients with cystic fibrosis appeared in recent years: prolongation of life expectancy with consequently increased comorbidities and the use of lung transplantation, systematic neonatal screening of new born since 2002, prescription of expensive new molecules or new presentation. This evolution justifies to realize an update of statistics of costs of care and to assess adherence to treatment

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 99 Years

Healthy volunteers

Inclusion criteria

* Patients with cystic fibrosis, * Followed by one of the cystic fibrosis center of the Rhône-Alpes region (pediatric and adult of Lyon and Grenoble) * Affiliated to the general scheme of health insurance, * And domiciled in the Rhône-Alpes region.

Exclusion criteria

* Transplanted patients

Design outcomes

Primary

Measure	Time frame
treatment cost	12 months

Secondary

Measure	Time frame
adherence rate for chronic treatment	12 months

Countries

France

Outcome results